论文信息 - Phase I/II trial of enzalutamide and mifepristone, a glucocorticoid receptor antagonist, for metastatic castration-resistant prostate cancer. - 字舞流文

Phase I/II trial of enzalutamide and mifepristone, a glucocorticoid receptor antagonist, for metastatic castration-resistant prostate cancer.

E. Heath | W. Stadler | T. Karrison | J. Wade | Anthony V. Serritella | Yen-Lin Chu | R. Szmulewitz | J. Schonhoft | D. Shevrin | A. Anderson | E. Martinez